MPLT
MapLight Therapeutics, Inc.
There isn't enough reported data to score MPLT yet.
MPLT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
MPLT's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
MPLT PE Valuation
MPLT has no meaningful PE right now: it lost money over the past year.
MPLT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| -- | |
| -- | |
| Limited | |
| Low |
Analysts expect MPLT's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
MPLT Earnings Per Share
MPLT Quarterly Revenue
MPLT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$44.9M | -$10.9M |
| Q1 2026 | -$51.2M | -$25.7M |
| Q4 2025 | -$47.2M | -$25.6M |
| Q2 2025 | -$34M | -$16.2M |
| Q1 2025 | -$25.6M | -$5.6M |
| Q1 2024 | -$19.9M | -$7.9M |
MPLT has burned cash in almost every quarter: −$177M over the past year, against −$85M the year before.
MPLT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -98% | -40.6M shares |
| 1 year | -98% | -40.6M shares |
MPLT has 791,127 diluted shares, down 98% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q1 2023 | — |
MPLT Net Leverage
MPLT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MPLT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.3 | Oversold |
| Stochastic | 8.2 | Oversold |
MPLT's weekly RSI is 29 (oversold) and its Stochastic is 8 (oversold).
MPLT PE vs Healthcare Sector
MPLT has no meaningful PE right now: it lost money over the past year.
MPLT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.29 | 15% below |
| 20 week MA | $15.8 | 55% below |
| 50 week MA | $19.9 | 64% below |
MPLT is in a downtrend: it's below all three of its weekly moving averages, and 64% below its 50-week average.
MPLT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $16.9 | $18.0 | +6.4% |
| 2026 YTD | $18.0 | $7.07 | -61% |
MPLT has finished every year since 2025 higher, and it's down 61% so far in 2026.